Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very dear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief for

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very clear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief fo

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ctive meeting with the Speaker [Wednesday]. ... I went through a very detailed proposal that I had just come from the Oval Office and reviewed with Mark Meadows and the President, so all three of us were very clear on what we wanted to do. I think it was a very fair proposal that provides a lot of relief fo